This post was originally published on this site The antioxidant MitoQ was seen to lower oxidative stress and inflammation in white blood cells from patients with type 2 diabetes. Since these factors are known contributors to heart disease, the findings suggest that mitochondrial supplements may be beneficial in preventing heart problems in these patients. The…
This post was originally published on this site Healthcare clinicians prescribe 15 times more anti-diabetes medications than they do anti-obesity drugs, missing an important opportunity to control both diseases, researchers reported. Their article, “Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s,” was published in the September issue…
This post was originally published on this site Investigators in an international research effort have found genetic evidence as to why the world’s most common treatment for type 2 diabetes, metformin, benefits some people more than others. Metformin has long been known to act differently on each patient, but the reasons for this largely confounded scientists. Researchers…
